Literature DB >> 7037038

Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2).

P M Dowd, M F Martin, E D Cooke, S A Bowcock, R Jones, P A Dieppe, J D Kirby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7037038     DOI： 10.1111/j.1365-2133.1982.tb00905.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  19 in total

Review 1.  Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension.

Authors:  Ezequiel Balmori Melian; Karen L Goa
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases.

Authors:  H I Torley; R Madhok; H A Capell; R M Brouwer; P J Maddison; C M Black; H Englert; J A Dormandy; H R Watson
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

3.  Inhibition of platelet aggregation by a new stable prostacyclin introduced in therapy of patients with progressive scleroderma.

Authors:  J Keller; A Kaltenecker; K T Schricker; B Neidhardt; O P Hornstein
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

Review 4.  Pathogenesis and treatment of Raynaud's phenomenon.

Authors:  J D Coffman
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

5.  Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis.

Authors:  M Rademaker; R H Thomas; G Provost; J A Beacham; E D Cooke; J D Kirby
Journal:  Postgrad Med J       Date:  1987-08       Impact factor: 2.401

6.  Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic Sclerosis.

Authors:  John D Pauling; Robyn T Domsic; Lesley A Saketkoo; Celia Almeida; Jane Withey; Hilary Jay; Tracy M Frech; Francesca Ingegnoli; Emma Dures; Joanna Robson; Neil J McHugh; Ariane L Herrick; Marco Matucci-Cerinic; Dinesh Khanna; Sarah Hewlett
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-08-16       Impact factor: 4.794

Review 7.  Nobel lecture. Adventures and excursions in bioassay--the stepping stones to prostacyclin.

Authors:  J R Vane
Journal:  Postgrad Med J       Date:  1983-12       Impact factor: 2.401

8.  Prostaglandin therapy in severe limb ischemia.

Authors:  B J Pardy; H H Eastcott
Journal:  World J Surg       Date:  1983-05       Impact factor: 3.352

9.  Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man.

Authors:  H Pickles; J O'Grady
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

10.  Cold-induced Raynaud's phenomenon ameliorated by intravenous administration of ketanserin: a double-blind cross-over study.

Authors:  H Baart de la Faille; H van Weelden; J D Banga; R G van Kesteren
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.